BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 11438887)

  • 1. Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21.
    McKay JD; Lesueur F; Jonard L; Pastore A; Williamson J; Hoffman L; Burgess J; Duffield A; Papotti M; Stark M; Sobol H; Maes B; Murat A; Kääriäinen H; Bertholon-Grégoire M; Zini M; Rossing MA; Toubert ME; Bonichon F; Cavarec M; Bernard AM; Boneu A; Leprat F; Haas O; Lasset C; Schlumberger M; Canzian F; Goldgar DE; Romeo G
    Am J Hum Genet; 2001 Aug; 69(2):440-6. PubMed ID: 11438887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Greek family with a follicular variant of familial papillary thyroid carcinoma: TCO, MNG1, fPTC/PRN, and NMTC1 excluded as susceptibility loci.
    Tsilchorozidou T; Vafiadou E; Yovos JG; Romeo G; McKay J; Lesueur F; Bonora E
    Thyroid; 2005 Dec; 15(12):1349-54. PubMed ID: 16405407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer.
    Bignell GR; Canzian F; Shayeghi M; Stark M; Shugart YY; Biggs P; Mangion J; Hamoudi R; Rosenblatt J; Buu P; Sun S; Stoffer SS; Goldgar DE; Romeo G; Houlston RS; Narod SA; Stratton MR; Foulkes WD
    Am J Hum Genet; 1997 Nov; 61(5):1123-30. PubMed ID: 9345104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for interaction between the TCO and NMTC1 loci in familial non-medullary thyroid cancer.
    McKay JD; Thompson D; Lesueur F; Stankov K; Pastore A; Watfah C; Strolz S; Riccabona G; Moncayo R; Romeo G; Goldgar DE
    J Med Genet; 2004 Jun; 41(6):407-12. PubMed ID: 15173224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2.
    Canzian F; Amati P; Harach HR; Kraimps JL; Lesueur F; Barbier J; Levillain P; Romeo G; Bonneau D
    Am J Hum Genet; 1998 Dec; 63(6):1743-8. PubMed ID: 9837827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. At least three genes account for familial papillary thyroid carcinoma: TCO and MNG1 excluded as susceptibility loci from a large Tasmanian family.
    McKay JD; Williamson J; Lesueur F; Stark M; Duffield A; Canzian F; Romeo G; Hoffman L
    Eur J Endocrinol; 1999 Aug; 141(2):122-5. PubMed ID: 10427154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide linkage analysis reveals evidence for four new susceptibility loci for familial euthyroid goiter.
    Bayer Y; Neumann S; Meyer B; Rüschendorf F; Reske A; Brix T; Hegedüs L; Langer P; Nürnberg P; Paschke R
    J Clin Endocrinol Metab; 2004 Aug; 89(8):4044-52. PubMed ID: 15292347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelic loss on chromosomes 2q21 and 19p 13.2 in oxyphilic thyroid tumors.
    Stankov K; Pastore A; Toschi L; McKay J; Lesueur F; Kraimps JL; Bonneau D; Gibelin H; Levillain P; Volante M; Papotti M; Romeo G
    Int J Cancer; 2004 Sep; 111(3):463-7. PubMed ID: 15221978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping a new familial thyroid epithelial neoplasia susceptibility locus to chromosome 8p23.1-p22 by high-density single-nucleotide polymorphism genome-wide linkage analysis.
    Cavaco BM; Batista PF; Sobrinho LG; Leite V
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4426-30. PubMed ID: 18765515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping of a gene predisposing to familial thyroid tumors with cell oxyphilia to chromosome 19 and exclusion of JUN B as a candidate gene.
    Kraimps JL; Canzian F; Jost C; Menet E; Amati P; Levillian P; Harach R; Lesueur F; Barbier J; Romeo G; Bonneau D
    Surgery; 1999 Dec; 126(6):1188-94. PubMed ID: 10598206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic heterogeneity in familial nonmedullary thyroid carcinoma: exclusion of linkage to RET, MNG1, and TCO in 56 families. NMTC Consortium.
    Lesueur F; Stark M; Tocco T; Ayadi H; Delisle MJ; Goldgar DE; Schlumberger M; Romeo G; Canzian F
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2157-62. PubMed ID: 10372725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome.
    Malchoff CD; Sarfarazi M; Tendler B; Forouhar F; Whalen G; Joshi V; Arnold A; Malchoff DM
    J Clin Endocrinol Metab; 2000 May; 85(5):1758-64. PubMed ID: 10843148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The FOXE1 locus is a major genetic determinant for familial nonmedullary thyroid carcinoma.
    Bonora E; Rizzato C; Diquigiovanni C; Oudot-Mellakh T; Campa D; Vargiolu M; Guedj M; ; McKay JD; Romeo G; Canzian F; Lesueur F
    Int J Cancer; 2014 May; 134(9):2098-107. PubMed ID: 24127282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial nonmedullary thyroid carcinoma.
    Malchoff CD; Malchoff DM
    Cancer Control; 2006 Apr; 13(2):106-10. PubMed ID: 16735984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomewide multipoint linkage analysis of seven extended Palauan pedigrees with schizophrenia, by a Markov-chain Monte Carlo method.
    Camp NJ; Neuhausen SL; Tiobech J; Polloi A; Coon H; Myles-Worsley M
    Am J Hum Genet; 2001 Dec; 69(6):1278-89. PubMed ID: 11668428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A susceptibility locus for papillary thyroid carcinoma on chromosome 8q24.
    He H; Nagy R; Liyanarachchi S; Jiao H; Li W; Suster S; Kere J; de la Chapelle A
    Cancer Res; 2009 Jan; 69(2):625-31. PubMed ID: 19147577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations.
    Zhu Z; Gandhi M; Nikiforova MN; Fischer AH; Nikiforov YE
    Am J Clin Pathol; 2003 Jul; 120(1):71-7. PubMed ID: 12866375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trisomy 17 as a marker for a subset of noninvasive thyroid nodules with focal features of papillary carcinoma: cytogenetic and molecular analysis of 62 cases and correlation with histological findings.
    Frau DV; Lai ML; Caria P; Dettori T; Coni P; Faa G; Morandi L; Tallini G; Vanni R
    J Clin Endocrinol Metab; 2008 Jan; 93(1):177-81. PubMed ID: 17956956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of PAX8-PPARgamma rearrangements is not specific to follicular thyroid carcinoma.
    Nakabashi CC; Guimarães GS; Michaluart P; Ward LS; Cerutti JM; Maciel RM
    Clin Endocrinol (Oxf); 2004 Aug; 61(2):280-2. PubMed ID: 15272927
    [No Abstract]   [Full Text] [Related]  

  • 20. Familial nonmedullary thyroid carcinoma.
    Malchoff CD; Malchoff DM
    Semin Surg Oncol; 1999; 16(1):16-8. PubMed ID: 9890735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.